Virtual Incision Stock

www.virtualincision.com/Healthcare / Medical DevicesFounded: 2006Funding to Date: $131.49MM

Virtual Incision is a robotic device company that assists medical surgeons. With a mission to create accessible robotic-assisted surgery (RAS), Virtual Incision uses miniRAS tray-to-table designs to enable shorter hospital stays and decrease open surgery conversions. In turn, the small design helps create minimally invasive surgeries for patients. Virtual Incision was founded by Dmitry Oleynikov and Shane Farritor in 2006 and is headquartered in Lincoln, Nebraska.

Register To Buy and Sell Shares

For more details on financing and valuation for Virtual Incision, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Virtual Incision’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Virtual Incision.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Virtual Incision investors also invested in these private companies

Baird Capital
Arboretum Ventures
Genesis Innovation Group
Endeavour Vision
Sinopharm Capital
Bluestem Capital Company
Invest Nebraska
PrairieGold Venture Partners
Invictum Capital

Team

Management Team

John Murphy
Chief Executive Officer & President
Mukund Srinivasan Ph.D
Chief Financial Officer
Shane Farritor Ph.D
Co-Founder & Chief Technology Officer
Dmitry Oleynikov MD
Co-Founder & Chief Surgeon
Piet Hinoul
Chief Medical Officer

Board Members

Amy Kobe
Baird Capital
Fernando Pacheco
Endeavour Vision
Robert Barmann
Endeavour Vision
Steve Kirby JD
Bluestem Capital Company
Tyler Stowater
Bluestem Capital Company

Frequently Asked Questions About Virtual Incision’s Stock

plusminus
Can you buy Virtual Incision’s stock?
Virtual Incision is not publicly traded on NYSE or NASDAQ in the U.S. To buy Virtual Incision’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Virtual Incision’s stock?
Yes, you can sell stock of a private company like Virtual Incision. Forge can help you sell your Virtual Incision stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Virtual Incision’s stock price?
Virtual Incision is a privately held company and therefore does not have a public stock price. However, you may access Virtual Incision’s private market stock price with Forge Data.
plusminus
What is Virtual Incision’s stock ticker symbol?
Virtual Incision does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Virtual Incision lets in another $30M for its surgical mini-robot
A little robot is leading to some big bucks. Assisted surgery developer Virtual Incision announced it has raised $30 million to help carry its operations through the next two years as it sets its sights on an FDA green light.
Virtual Incision submits surgical robot for FDA de novo review
Virtual Incision announced that it submitted its MIRA surgical robot to the FDA for de novo review. Lincoln, Nebraska-based Virtual Incision seeks authorization to market MIRA for use in bowel resection procedures. The submission follows a completed FDA investigational device exemption (IDE) study. FDA approved the IDE supplement for MIRA in April 2022.
Updated on: May 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.